Skip to content
Baret News – Lifestyle
Author:
UE Systems
Femasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc®
August 20, 2026
Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update
August 17, 2026
Femasys Strengthens and Extends Global Patent Protection for FemBloc® with First Issued Blended Polymer Patents
August 12, 2026
Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
August 7, 2026
Femasys Regains Compliance with Nasdaq Listing Requirements
June 24, 2026
Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter
May 22, 2026
Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
May 21, 2026
UE Systems Introduces UE ONE™, Turning What Industry Hears Into Action
May 21, 2026